Recall Enforment Report D-1030-2018

Recall Details

Drug Recall Enforcement Report Class I voluntary initiated by AuroMedics Pharma LLC, originally initiated on 07-02-2018 for the product Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30 The product was recalled due to presence of particulate matter: identified as glass and silicone material. The product was distributed nationwide and the recall is currently terminated.

Field Name Field Value
Event ID 80390 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-1030-2018 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern Nationwide in the USA What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30
Reason For Recall Presence of Particulate Matter: identified as glass and silicone material What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 73620 single-dose vials Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 07-18-2018
Recall Initiation Date 07-02-2018 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Termination Date 10-01-2024 What is the Date Terminated?
The date that FDA terminated the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm AuroMedics Pharma LLC
Code Info Lot: PP0317059-A; Exp February 2019: PP0317012-A, Exp: August 2019. Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 55150-119-30; 55150-120-30; 55150-121-50
Status Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
55150-119Piperacillin And Tazobactam Piperacillin Sodium And Tazobactam SodiumInjection, Powder, Lyophilized, For SolutionIntravenousEugia Us LlcHuman Prescription Drug
55150-120Piperacillin And Tazobactam Piperacillin Sodium And Tazobactam SodiumInjection, Powder, Lyophilized, For SolutionIntravenousEugia Us LlcHuman Prescription Drug
55150-121Piperacillin And Tazobactam Piperacillin Sodium And Tazobactam SodiumInjection, Powder, Lyophilized, For SolutionIntravenousEugia Us LlcHuman Prescription Drug